189 related articles for article (PubMed ID: 28069321)
1. Consumer confusion between prescription drug precautions and side effects.
Amoozegar JB; Rupert DJ; Sullivan HW; O'Donoghue AC
Patient Educ Couns; 2017 Jun; 100(6):1111-1119. PubMed ID: 28069321
[TBL] [Abstract][Full Text] [Related]
2. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.
Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ
J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069
[TBL] [Abstract][Full Text] [Related]
3. Actors in whitespace: Communicating risk information on pharmaceutical websites.
O'Donoghue AC; Sullivan HW; Rupert DJ; Fitts Willoughby J; Aikin KJ
Health Mark Q; 2019; 36(2):152-167. PubMed ID: 30907290
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the educational value of direct-to-consumer advertising of prescription drugs.
Hwang MJ; Young HN
J Am Pharm Assoc (2003); 2017; 57(5):571-578. PubMed ID: 28676435
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Information on Oncology Prescription Drug Websites.
Sullivan HW; Aikin KJ; Squiers LB
J Cancer Educ; 2018 Apr; 33(2):371-374. PubMed ID: 27589969
[TBL] [Abstract][Full Text] [Related]
6. Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.
Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Amoozegar JB; Aikin KJ
J Health Commun; 2016 Nov; 21(11):1198-1207. PubMed ID: 27805473
[TBL] [Abstract][Full Text] [Related]
7. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising.
Jiang P
Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729
[TBL] [Abstract][Full Text] [Related]
8. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
Aikin KJ; Sullivan HW; Betts KR
J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
[TBL] [Abstract][Full Text] [Related]
9. Disclosing accelerated approval on direct-to-consumer prescription drug websites.
Sullivan HW; O'Donoghue AC; David KT; Patel NJ
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1277-1280. PubMed ID: 30264874
[TBL] [Abstract][Full Text] [Related]
10. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
[No Abstract] [Full Text] [Related]
12. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
[TBL] [Abstract][Full Text] [Related]
13. Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions.
Sullivan HW; O'Donoghue AC; Gard Read J; Amoozegar JB; Aikin KJ; Rupert DJ
J Med Internet Res; 2018 Jan; 20(1):e13. PubMed ID: 29362205
[TBL] [Abstract][Full Text] [Related]
14. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
[TBL] [Abstract][Full Text] [Related]
15. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
[TBL] [Abstract][Full Text] [Related]
16. Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study.
Schulz PJ; Crosignani F; Petrocchi S
J Med Internet Res; 2023 Jul; 25():e40616. PubMed ID: 37459159
[TBL] [Abstract][Full Text] [Related]
17. Optimistic bias, advertising skepticism, and consumer intentions for seeking information about the health risks of prescription medicine.
Park JS; Ahn HA; Haley EJ
Health Mark Q; 2017; 34(2):81-96. PubMed ID: 28590885
[TBL] [Abstract][Full Text] [Related]
18. Consumer tradeoff of advertising claim versus efficacy information in direct-to-consumer prescription drug ads.
Aikin KJ; Betts KR; Ziemer KS; Keisler A
Res Social Adm Pharm; 2019 Dec; 15(12):1484-1488. PubMed ID: 30846370
[TBL] [Abstract][Full Text] [Related]
19. A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea.
Yang YM; Lee JJ; Jeong E; Kim SY; Han MA; Choi EJ
PLoS One; 2018; 13(7):e0201108. PubMed ID: 30040833
[TBL] [Abstract][Full Text] [Related]
20. Effects of image congruency on persuasiveness and recall in direct-to-consumer prescription drug advertising.
Kiernicki K; Helme DW
Health Mark Q; 2017; 34(4):284-301. PubMed ID: 29173108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
